MCT2D
US$ 20.52
hyperthyroidism glp 1 GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists Graves' Disease and GLP-1 Weight
Description
The column was pre-equilibrated with 20 mM HEPES, pH 7.4, 100 mM NaCl, 5 M GLP-2, 100 M TCEP, 2 mM MgCl 2 , 0.00075% (w/v) LMNG, 0.00025% (w/v) GDN and 0.0002% (w/v) CHS
It is short acting and taken by twice daily injections
Gallbladder disease including cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation) has been reported with GLP-1 receptor agonists
or meningioma (low certainty)
doi: 10.3945/ajcn.2009.27465 [DOI] [PMC free article] [PubMed] [Google Scholar] 78
The primary endpoint was a new diagnosis of GERD
